Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications

Citation
L. Harel et al., Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications, J RHEUMATOL, 28(5), 2001, pp. 1129-1132
Citations number
14
Categorie Soggetti
Rheumatology,"da verificare
Journal title
JOURNAL OF RHEUMATOLOGY
ISSN journal
0315162X → ACNP
Volume
28
Issue
5
Year of publication
2001
Pages
1129 - 1132
Database
ISI
SICI code
0315-162X(200105)28:5<1129:TOCIJD>2.0.ZU;2-5
Abstract
Objective. To report the efficacy of probenecid for calcinosis of juvenile dermatomyositis (JDM) and assess the changes in phosphorus metabolism durin g treatment. Methods. Biochemical studies of calcium and phosphorus metabolism were perf ormed in a 9-year-old girl with JDM and extensive calcifications before and during probenecid treatment. Results. The calcifications resolved over 18 months of treatment, Probeneci d was found to be effective in reducing calcifications by increasing renal phosphate clearance. Conclusions. The tendency for calcifications in some patients with JDM migh t be related to an increase in renal phosphate reclamation, and therefore; probenecid treatment may be effective in these patients.